Global Health Exhibition adds investor access for healthcare startups

Global Health Exhibition 2026 is expanding its NextGen Pitch Competition in Riyadh with direct access to more than 1,000 investors and a dedicated Capital Xchange Programme. The move is designed to help emerging healthcare companies raise capital, build partnerships and speed commercialization ahead of the 26-29 October event.

Why it matters: - Global Health Exhibition 2026 is using its platform to give healthcare startups and scaleups more direct access to capital, partners and customers. - The expanded investor programming is aimed at faster commercialization for companies building Digital Health, AI in Healthcare, Bio and Life Sciences, and MedTech solutions. - Saudi Arabia’s healthcare investment push is getting another visible showcase as the Kingdom positions itself as a hub for innovation and market growth.

What happened: - Global Health Exhibition 2026 said its NextGen Pitch Competition will connect 54 healthcare startups and scaleups with more than 250 senior leaders managing $65 billion in assets. - The competition will take place from 26-29 October in Riyadh. - Semi-finalists and finalists will pitch live to investors, healthcare leaders and decision-makers. - Applications for NextGen 2026 are now open at the NextGen application site.

The details: - The competition is open to companies working in Digital Health and AI in Healthcare, Bio and Life Sciences, and MedTech. - Participants will get one-to-one investor matchmaking, mentorship from healthcare and investment leaders, promotion on the event website and access to organizations seeking to fund, adopt and scale new healthcare solutions. - Winners will share a SAR 100,000 prize fund. - New for 2026, every semi-finalist and finalist will join an exclusive Power Networking Breakfast with investors in the Capital Xchange Programme. - Global Health Exhibition expects more than 1,000 investors to attend the event. - Capital Xchange will convene more than 250 senior leaders through an invite-only program of networking, site visits and private discussions. - The 2025 investor group represented more than $65 billion in assets under management across 40 countries. - Confirmed 2026 participants include TVM Capital Healthcare, Abdul Latif Jameel Enterprises, Bupa’s investment arm, Mayo Clinic and Redesign Health. - Confirmed 2026 exhibitors include Mayo Clinic, Karl Storz, Canon Medical Systems, BD, Stryker and Baxter. - Global Health Exhibition will showcase artificial intelligence, digital health, robotics, diagnostics and precision medicine.

Between the lines: - The new breakfast session and broader investor access suggest Tahaluf is trying to turn the pitch competition into a more structured deal-making venue, not just a showcase. - The emphasis on strategic investors, sovereign wealth funds, family offices and private equity reflects the growing importance of non-traditional funding in healthcare innovation. - Tahaluf also pointed to MAGNiTT data showing corporate investors took part in 37% of all venture capital raised across MENA between 2021 and 2025. - Rachel Sturgess, senior vice president at Tahaluf, said access is often the biggest barrier to growth for healthcare innovators. - ExoHeal founder and CEO Zain Samdani said the 2025 competition accelerated investor conversations that might otherwise have taken months. - Sylke founder and CEO M. Mark Mofid said structured access to investors and partners is what makes Global Health Exhibition valuable.

What's next: - NextGen 2026 semifinalists and finalists will pitch in Riyadh during the October event. - Global Health Exhibition will continue positioning itself as a meeting point for healthcare innovation, investment and policy. - Organizers are likely to use the expanded investor program to attract more startups, funders and strategic partners in future editions.

The bottom line: - Global Health Exhibition is widening the funnel between healthcare founders and capital, betting that more structured investor access will translate into faster growth and real-world adoption.